New and recently funded Medical Startups
1
Country: USA | Funding: $213M
Epicrispr intends to treat rare muscle degeneration disease FSHD, which currently lacks approved therapies. It focuses on using epigenetic modification to modulate protein expression without directly editing DNA. Its drug candidate has already showed increases in lean muscle mass in patients during clinical trials.
Epicrispr intends to treat rare muscle degeneration disease FSHD, which currently lacks approved therapies. It focuses on using epigenetic modification to modulate protein expression without directly editing DNA. Its drug candidate has already showed increases in lean muscle mass in patients during clinical trials.
2
Country: USA
SpaceMD is a biotechnology company that focuses on microgravity environment to create pharmaceutical products.
SpaceMD is a biotechnology company that focuses on microgravity environment to create pharmaceutical products.
3
Country: Switzerland | Funding: $43.5M
Transmutex develops designs and software for an accelerator-powered technology that turns existing nuclear waste into clean energy and produces radioisotopes for medical and industrial applications. The startup is set to revolutionize the field of cancer diagnosis and treatment through the advanced production and development of radioactive isotopes. By extracting these elements from nuclear waste or directly producing them with its proton accelerator, the company intends to transform the landscape of medical diagnostics.
Transmutex develops designs and software for an accelerator-powered technology that turns existing nuclear waste into clean energy and produces radioisotopes for medical and industrial applications. The startup is set to revolutionize the field of cancer diagnosis and treatment through the advanced production and development of radioactive isotopes. By extracting these elements from nuclear waste or directly producing them with its proton accelerator, the company intends to transform the landscape of medical diagnostics.
4
Country: USA | Funding: $87M
Infinimmune develops human-derived antibody medicines using B-cell sequencing, computational modeling, and antibody engineering technology. The startup is backed by Regeneron that is financing the development of a potential competitor to its inflammation blockbuster Dupixent for treating eczema, asthma, and COPD.
Infinimmune develops human-derived antibody medicines using B-cell sequencing, computational modeling, and antibody engineering technology. The startup is backed by Regeneron that is financing the development of a potential competitor to its inflammation blockbuster Dupixent for treating eczema, asthma, and COPD.
5
Country: Egypt
digital healthcare platform that helps patients discover trusted doctors, book appointments, and manage their medical journey in one place. Its goal is to simplify healthcare access and make medical services more accessible across Egypt and the region
digital healthcare platform that helps patients discover trusted doctors, book appointments, and manage their medical journey in one place. Its goal is to simplify healthcare access and make medical services more accessible across Egypt and the region
6
Country: USA | Funding: $276.8M
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.
7
Country: USA | Funding: $31M
Rylo offers an FCC-certified platform for deaf and hard-of-hearing users that provides real-time captioning and text-to-speech capabilities for phone calls and in-person communication. It develops additional AI-powered tools for workplace accessibility, network improvements, speaker characteristics, sentiment analysis and real-time fraud detection.
Rylo offers an FCC-certified platform for deaf and hard-of-hearing users that provides real-time captioning and text-to-speech capabilities for phone calls and in-person communication. It develops additional AI-powered tools for workplace accessibility, network improvements, speaker characteristics, sentiment analysis and real-time fraud detection.
8
Country: USA | Funding: $22.6M
Fesarius Therapeutics is focused on dermal repair. Its lead product, DermiSphere hDRT, is FDA-cleared hydrogel dermal regeneration template designed for wound management. It's as a dual-density collagen hydrogel template that supports cellular invasion and vascularized tissue regeneration. The company said also develops OneStep procedure that DermiSphere and a split-thickness skin graft to be applied simultaneously and thus reduce recovery time, pain and total cost of care (in comparison with current two-stage approach for some full-thickness skin-loss cases, when a surgeon places a dermal substitute in one procedure, and then the patient returns for a second surgery after the template has vascularized enough to support a skin graft).
Fesarius Therapeutics is focused on dermal repair. Its lead product, DermiSphere hDRT, is FDA-cleared hydrogel dermal regeneration template designed for wound management. It's as a dual-density collagen hydrogel template that supports cellular invasion and vascularized tissue regeneration. The company said also develops OneStep procedure that DermiSphere and a split-thickness skin graft to be applied simultaneously and thus reduce recovery time, pain and total cost of care (in comparison with current two-stage approach for some full-thickness skin-loss cases, when a surgeon places a dermal substitute in one procedure, and then the patient returns for a second surgery after the template has vascularized enough to support a skin graft).
9
Country: USA | Funding: $46M
Vedana Therapeutics is developing next-generation antibody therapies for migraine prevention. The biotech’s lead program is an anti-PACAP antibody, while its second program is a bispecific antibody targeting both PACAP and CGRP that is designed to treat patients who have not found relief with monotherapies. CGRP is a messenger protein in the nervous system that is released in excess during a migraine attack, causing blood vessels in the brain's outer lining to dilate and triggering severe inflammation and pain. PACAP is a neuropeptide that widens blood vessels and transmits pain signals.
Vedana Therapeutics is developing next-generation antibody therapies for migraine prevention. The biotech’s lead program is an anti-PACAP antibody, while its second program is a bispecific antibody targeting both PACAP and CGRP that is designed to treat patients who have not found relief with monotherapies. CGRP is a messenger protein in the nervous system that is released in excess during a migraine attack, causing blood vessels in the brain's outer lining to dilate and triggering severe inflammation and pain. PACAP is a neuropeptide that widens blood vessels and transmits pain signals.
10
Country: USA | Funding: $11.6M
Clair Health creates a menopause-focused wearable gadget that is able to determine what is causing hormones to change and how the body responds to those changes by evaluating the biomarkers picked up by its sensors. It also continuously monitors changes through the four phases of a menstruation cycle and doesn’t just rely on the day of menstruation. Through these markers, the app shows information about the pace of aging, inflammation and bloating, and the rate of perceived exertion. The company has trained its own AI to analyze voice-based biomarkers and determine which phase of their cycle a user is in after just a few minutes of conversation.
Clair Health creates a menopause-focused wearable gadget that is able to determine what is causing hormones to change and how the body responds to those changes by evaluating the biomarkers picked up by its sensors. It also continuously monitors changes through the four phases of a menstruation cycle and doesn’t just rely on the day of menstruation. Through these markers, the app shows information about the pace of aging, inflammation and bloating, and the rate of perceived exertion. The company has trained its own AI to analyze voice-based biomarkers and determine which phase of their cycle a user is in after just a few minutes of conversation.
